(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SARCONEOS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SARCONEOS

ST13

US500000079207745

Class

3, 5, 42

Filing

79207745

Registration

5398665

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

12/01/2025

Trademark type

Word

Nice classes

3, 5, 42

Filing date

08/03/2016

Registration date

02/13/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/30/2024

Last transaction

12/01/2025

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

33

Owner location

FR

Examiner

LE,KHANH M

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BIOPHYTIS, société anonyme

Representatives

Cynthia A. Moyer Fredrikson & Byron, P.A.

Technical classification

Nice Classes

Class 3Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Soapsperfumed soapsbeauty soapsshaving soapsbath soapscosmetic soaps; perfumesessential oilscosmeticshair lotions; slimming cosmetic preparations for external use

Class 5

Pharmaceutical products for the prevention and treatment of muscular diseasessarcopeniacachexiesgenetic muscular diseases; pharmaceutical products for the prevention and treatment of metabolic diseasesdiabetesobesity and cardiovascular diseases; dietetic substancescapsulestabletsbarssachetsliquidsjelliespowders based of amino acidsmineralsmineral saltsvitaminsproteins to prevent the oxidation of the bodythe cardiovascular diseasesto improve visionto improve the articular flexibilityto promote relaxationto strengthen the immune systems and foods for medical use; food supplements for human beings; sanitary products for medical purposesmedicinal astringentsdisinfectants for medical instrumentsmedicated body care soapsdisinfectant soapsmedicated personal soapsantifungal creams for medical usemedicated lotions for the body and shampoos without rinsingrubbing alcohol for medical usemedicated skin cleansers for medical use; medical plasters; materials for medical dressingsbandagesdressings and medical gauzesabsorbent cotton for bandagesbands and strips for bandages; material for stopping teeth and for dental impressions; disinfectants; preparations for destroying vermin; fungicides; herbicides; medicated baths preparations; sanitary padspanties or towels; chemical preparations for pharmaceutical usepreventive pharmaceutical agents for cerebral hemorrhagerelease agents of medicines in the form of edible wafers for the conditioning of pharmaceutical products in the form of powdermedicated pharmaceutical astringents; parasiticides; dietetic sugar for medical use; alloys of precious metals for dental use; dietetic substances for medical use produced by organic farming or made with goods produced by organic farmingsupplements with extracts of plants for the treatment of muscle diseasesnamely sarcopeniacachexiagenetic muscular dystrophiesmetabolic diseasesdiabetesobesity and cardiovascular diseases; food for babies

Class 42

Evaluationsassessments and research in the fields of science and technology provided by engineers; research and development of new products for others; technical project studies in scientific and technologic fieldsfeasibility studies in the field of new technologies; technological studies in the field of pharmaceutical research and development; technical research in the field of pharmaceutical research and development; research in the field of pharmaceutical products; biologicalmedical research services; clinical research in the field of pharmaceuticals; biotechnological research; scientific research for medical purposes; computer-aided scientific research services; information relating to scientific research; preparation of reports relating to scientific research; advice relating to research and development in the therapeutic field of pharmaceuticals; providing information and data relating to medical and veterinary research and development; design and development of computers and software; installationmaintenance and updating or rental of software; programming for computers; consultancy relating to computers; conversion of computer programs and data other than physical conversion; conversion of documents from a physical medium to an electronic medium

Publications

History of USPTO decisions and trademark events.

37 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/30/2025

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

09/05/2025

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

08/16/2025

INPC

INVALIDATION PROCESSED

08/16/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

04/30/2025

C71T

CANCELLED SECTION 71

08/30/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

02/13/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/29/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/17/2018

FIMP

FINAL DISPOSITION PROCESSED

05/17/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/13/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

02/13/2018

GPNX

NOTIFICATION PROCESSED BY IB

12/09/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/28/2017

PUBO

PUBLISHED FOR OPPOSITION

11/28/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/22/2017

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/22/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/08/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/26/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/14/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/14/2017

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

10/14/2017

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

10/11/2017

GNFR

FINAL REFUSAL E-MAILED

10/11/2017

CNFR

FINAL REFUSAL WRITTEN

10/11/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/21/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/20/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/20/2017

RFNT

REFUSAL PROCESSED BY IB

07/01/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/09/2017

RFRR

REFUSAL PROCESSED BY MPU

06/09/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/27/2017

MAFR

APPLICATION FILING RECEIPT MAILED

05/27/2017

CNRT

NON-FINAL ACTION WRITTEN

05/26/2017

DOCK

ASSIGNED TO EXAMINER

05/23/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/23/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/18/2017

Continuous trademark protection

Get notified about every new filing that threatens SARCONEOS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.